Compare RCMT & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCMT | LNSR |
|---|---|---|
| Founded | 1971 | 2004 |
| Country | United States | United States |
| Employees | N/A | 140 |
| Industry | Professional Services | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 136.8M |
| IPO Year | N/A | N/A |
| Metric | RCMT | LNSR |
|---|---|---|
| Price | $20.05 | $11.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $30.00 | $15.00 |
| AVG Volume (30 Days) | 39.6K | ★ 42.8K |
| Earning Date | 11-05-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $309,840,000.00 | $59,141,000.00 |
| Revenue This Year | $15.20 | $19.55 |
| Revenue Next Year | $7.50 | $35.89 |
| P/E Ratio | $11.79 | ★ N/A |
| Revenue Growth | 13.70 | ★ 21.02 |
| 52 Week Low | $13.18 | $7.25 |
| 52 Week High | $28.27 | $17.31 |
| Indicator | RCMT | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 51.37 |
| Support Level | $19.82 | $11.19 |
| Resistance Level | $20.55 | $11.81 |
| Average True Range (ATR) | 0.64 | 0.31 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 20.62 | 35.96 |
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.